Latest News & Insights
Catch up on announcements, research highlights, and insights from the Virginia Cancer Specialists team.
6 months ago
Dr. Patricia Rodriguez of Virginia Cancer Specialists, is a co-author of the joint guideline paper issued by the American Society of Clinical Oncology (ASCO) and the Society of Surgical Oncology (SSO) that aims to
3 years ago
Exciting News! Our Woodbridge Office is relocating to a New Suite on January 29th! Join us in welcoming our providers, staff and patients to its new, state-of-the-art location. Mark your calendars for January 29th
3 years ago
Endocrine therapy remains a mainstay in the treatment of early-stage hormone receptor-positive breast cancer. However, oncologists continue to work on improving the risk of recurrence in patients whose tumors exhibit high-risk features, such as
A recent study published by Dr. Dipti Patel-Donnelly, of Virginia Cancer Specialists and colleagues has shed light on a groundbreaking approach in the treatment of advanced-stage classical Hodgkin lymphoma (cHL) in older patients. This
As a society, we can do better when it comes to healthy eating. Case in point – according to the USDA, the average Healthy Eating Index score (a measurement of overall diet quality) is
3 years ago
Introduction: Lung cancer remains one of the most challenging and life-threatening diseases; however, several exciting treatment advances show promising benefits. A recent study in which Virginia Cancer Specialists participated under the research leadership of
November is Lung Cancer Awareness Month. In recent years, lung cancer treatment has taken incredible steps forward, thanks to breakthrough research and early detection. Here are some of the latest advancements in treating lung
Lung cancer poses a significant healthcare challenge in the United States, with approximately 237,000 individuals newly diagnosed each year. Although the majority of cases are found at an advanced stage, approximately 25-35% of cases
Detecting cancer at an early, treatable stage remains challenging, but new technologies are offering hope. The PATHFINDER study <Blood-based tests for multicancer early detection (PATHFINDER): a prospective cohort study>, conducted by a team of
Patients undergoing treatment for breast or gastrointestinal cancers with the chemotherapy drug capecitabine (Xeloda®) may develop hand-foot syndrome (HFS). A common treatment side-effect, HFS can lead to redness, swelling, skin peeling, and sometimes painful